Mostrar el registro sencillo del ítem

dc.contributor.authorLopez-Caraballo, Lidia
dc.contributor.authorMartorell Marugán, Jordi 
dc.contributor.authorCarmona Sáez, Pedro 
dc.contributor.authorGonzález-Múñoz, Elena
dc.date.accessioned2020-11-06T10:12:14Z
dc.date.available2020-11-06T10:12:14Z
dc.date.issued2020-07-29
dc.identifier.citationLopez-Caraballo, L.; Martorell-Marugan, J.; Carmona-Sáez, P.; Gonzalez-Munoz, E. iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation. Cells 2020, 9, 1803. [doi:10.3390/cells9081803]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/64094
dc.descriptionThis research was funded by Ministerio de Economia y Competitividad Gobierno de Espana (RYC-2014-15410 and SAF2015-66105-R), Fundacion GENZYME, Consejeria Economia y Conocimiento Junta de Andalucia-FEDER (UMA18-FEDERJA-107) and Fundacion Progreso y Salud.es_ES
dc.description.abstractThe most challenging aspect of secondary progressive multiple sclerosis (SPMS) is the lack of efficient regenerative response for remyelination, which is carried out by the endogenous population of adult oligoprogenitor cells (OPCs) after proper activation. OPCs must proliferate and migrate to the lesion and then differentiate into mature oligodendrocytes. To investigate the OPC cellular component in SPMS, we developed induced pluripotent stem cells (iPSCs) from SPMS-affected donors and age-matched controls (CT). We confirmed their efficient and similar OPC differentiation capacity, although we reported SPMS-OPCs were transcriptionally distinguishable from their CT counterparts. Analysis of OPC-generated conditioned media (CM) also evinced differences in protein secretion. We further confirmed SPMS-OPC CM presented a deficient capacity to stimulate OPC in vitro migration that can be compensated by exogenous addition of specific components. Our results provide an SPMS-OPC cellular model and encouraging venues to study potential cell communication deficiencies in the progressive form of multiple sclerosis (MS) for future treatment strategies.es_ES
dc.description.sponsorshipMinisterio de Economia y Competitividad Gobierno de Espana RYC-2014-15410 SAF2015-66105-Res_ES
dc.description.sponsorshipFundación GENZYME, Consejería Economía y Conocimiento Junta de Andalucía-FEDER UMA18-FEDERJA-107es_ES
dc.description.sponsorshipFundación Progreso y Saludes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectSecondary progressive multiple sclerosis (SPMS)es_ES
dc.subjectDisease modeling; iPSCses_ES
dc.subjectOligodendrocyte progenitor cells (OPCs)es_ES
dc.subjectSecretomees_ES
dc.subjectCell migrationes_ES
dc.titleiPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulationes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/cells9081803
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España